Fujifilm Cellular Dynamics, Inc.
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Previously recorded as Cellular Dynamics International, Inc. (to 2018)
12
Ending by 2030
Jun 2029
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 19, 2026The maintenance fee for Metabolic maturation in stem cell-derived tissue cells (US 9,034,584) comes due Nov 19, 2026. Unpaid by May 19, 2027, it lapses early.
- 1 fee due Apr 15, 2027The maintenance fee for Neural networks formed from cells derived from pluripotent stem cells (US 10,444,227) comes due Apr 15, 2027. Unpaid by Oct 15, 2027, it lapses early.
- 2 fees due May 3 to 10, 2027 · next May 3
- 1 fee due Aug 16, 2027The maintenance fee for Hepatocyte production by forward programming (US 9,260,722) comes due Aug 16, 2027. Unpaid by Feb 16, 2028, it lapses early.
- 3 fees due Sep 17 to 30, 2027 · next Sep 17
- 1 fee due Nov 3, 2027The maintenance fee for Methods for the production of IPS cells using non-viral approach (US 9,328,332) comes due Nov 3, 2027. Unpaid by May 3, 2028, it lapses early.
Recent changes
- 4 of the patents on this record were granted since Aug 17, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,644,184 | Methods for the production of IPS cells using Epstein-Barr (EBV)-based reprogramming vectors In force · From the USPTO record | In force | From the USPTO record | |
| US 9,175,268 | Methods for the production of iPS cells In force · From the USPTO record | In force | From the USPTO record | |
| US 9,328,332 | Methods for the production of IPS cells using non-viral approach In force · From the USPTO record | In force | From the USPTO record | |
| US 8,546,140 | Methods for the production of iPS cells using non-viral approach In force · From the USPTO record | In force | From the USPTO record | |
| US 8,372,642 | Differentiation of pluripotent cells In force · From the USPTO record | In force | From the USPTO record | |
| US 9,347,044 | Reprogramming T cells and hematopoietic cells In force · From the USPTO record | In force | From the USPTO record | |
| US 10,221,396 | Reprogramming T cells and hematopoietic cells In force · From the USPTO record | In force | From the USPTO record | |
| US 8,741,648 | Reprogramming T cells and hematopoietic cells In force · From the USPTO record | In force | From the USPTO record | |
| US 9,365,827 | Cardiomyocyte production In force · From the USPTO record | In force | From the USPTO record | |
| US 9,957,482 | Cardiomyocyte production In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 53: 2 patents in force now held by others. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
13 pending · 2 abandoned · 5 no status recorded